Eric Ostertag's Insider Trades & SAST Disclosures
Eric Ostertag's most recent trade in Poseida Therapeutics Inc was a trade of 11,776 Common Stock done at an average price of $7 . Disclosure was reported to the exchange on Feb. 1, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric Ostertag.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Poseida Therapeutics Inc | Eric Ostertag | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 01 Feb 2023 | 11,776 | 827,320 | - | 7 | 82,432 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 08 Aug 2022 | 142,857 | 838,824 | - | 3.5 | 500,000 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.69 per share. | 03 Aug 2022 | 160,696 | 0 | - | 3.7 | 592,808 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 118,708 | 118,708 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2022 | 93,955 | 603,467 | - | 0 | Common Stock | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 89,500 | 692,967 | - | 0 | Common Stock | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2022 | 48,902 | 580,292 | - | 0 | Common Stock | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 10,792 | 10,792 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. | 19 Nov 2021 | 1,000 | 697,422 | - | 9.2 | 9,150 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 1,000 | 739,995 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 08 Nov 2021 | 9,873 | 3,659,503 | - | 7.1 | 70,000 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 08 Nov 2021 | 9,051 | 3,358,455 | - | 7.1 | 64,172 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. | 11 Oct 2021 | 18,525 | 696,422 | - | 9.2 | 169,504 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 18,525 | 740,995 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.02 per share. | 01 Oct 2021 | 10,450 | 3,669,376 | - | 7.0 | 73,359 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.02 per share. | 01 Oct 2021 | 9,579 | 3,367,506 | - | 7.0 | 67,245 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 20 Sep 2021 | 20,000 | 160,696 | - | 8.0 | 160,020 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.14 per share. | 13 Sep 2021 | 20,000 | 180,696 | - | 8.1 | 162,712 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 18,524 | 759,520 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. | 13 Sep 2021 | 18,524 | 675,415 | - | 9.2 | 169,495 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 2,757 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. | 13 Sep 2021 | 2,757 | 656,891 | - | 1.2 | 3,234 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 01 Sep 2021 | 31,963 | 3,679,826 | - | 8.3 | 266,571 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 01 Sep 2021 | 29,299 | 3,377,085 | - | 8.3 | 244,354 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 01 Sep 2021 | 26,686 | 3,711,789 | - | 8.5 | 225,764 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 01 Sep 2021 | 24,463 | 3,406,384 | - | 8.5 | 206,957 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 111,149 | 778,044 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.15 per share. | 06 Aug 2021 | 111,149 | 654,134 | - | 9.1 | 1,017,013 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.99 per share. | 02 Aug 2021 | 10,401 | 3,738,475 | - | 8.0 | 83,104 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.99 per share. | 02 Aug 2021 | 9,535 | 3,430,847 | - | 8.0 | 76,185 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.13 per share. | 02 Aug 2021 | 7,167 | 3,748,876 | - | 8.1 | 58,268 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.13 per share. | 02 Aug 2021 | 6,570 | 3,440,382 | - | 8.1 | 53,414 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.90 per share. | 01 Jul 2021 | 14,266 | 3,756,043 | - | 8.9 | 126,967 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.90 per share. | 01 Jul 2021 | 13,076 | 3,446,952 | - | 8.9 | 116,376 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.77 per share. | 01 Jul 2021 | 10,729 | 3,770,413 | - | 9.8 | 104,822 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.77 per share. | 01 Jul 2021 | 9,834 | 3,460,124 | - | 9.8 | 96,078 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.65 per share. | 01 Jul 2021 | 104 | 3,770,309 | - | 9.7 | 1,004 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.65 per share. | 01 Jul 2021 | 96 | 3,460,028 | - | 9.6 | 926 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 01 Jun 2021 | 21,493 | 3,802,388 | - | 8.6 | 185,055 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 01 Jun 2021 | 21,246 | 3,781,142 | - | 8.3 | 177,192 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 01 Jun 2021 | 19,701 | 3,489,434 | - | 8.6 | 169,626 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 01 Jun 2021 | 19,476 | 3,469,958 | - | 8.3 | 162,430 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 03 May 2021 | 18,775 | 3,823,881 | - | 8.4 | 158,461 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.44 per share. | 03 May 2021 | 17,211 | 3,509,135 | - | 8.4 | 145,261 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 03 May 2021 | 9,561 | 3,842,656 | - | 9.0 | 86,145 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 03 May 2021 | 8,765 | 3,526,346 | - | 9.0 | 78,973 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.55 per share. | 01 Apr 2021 | 29,834 | 3,882,383 | - | 9.6 | 285,046 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 01 Apr 2021 | 28,549 | 3,853,834 | - | 9.6 | 274,784 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.55 per share. | 01 Apr 2021 | 27,347 | 3,560,277 | - | 9.6 | 261,284 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 01 Apr 2021 | 26,170 | 3,534,107 | - | 9.6 | 251,886 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.32 per share. | 01 Apr 2021 | 1,617 | 3,852,217 | - | 10.3 | 16,691 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.32 per share. | 01 Apr 2021 | 1,483 | 3,532,624 | - | 10.3 | 15,307 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 01 Mar 2021 | 29,770 | 3,912,217 | - | 11.5 | 343,516 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.66 per share. | 01 Mar 2021 | 29,702 | 3,942,515 | - | 11.7 | 346,325 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 01 Mar 2021 | 27,290 | 3,590,111 | - | 11.5 | 314,899 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.66 per share. | 01 Mar 2021 | 27,226 | 3,617,885 | - | 11.7 | 317,455 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 01 Mar 2021 | 528 | 3,941,987 | - | 12.1 | 6,399 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 01 Mar 2021 | 484 | 3,617,401 | - | 12.1 | 5,866 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. | 23 Feb 2021 | 111,395 | 542,985 | - | 1.2 | 130,666 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 111,395 | 2,757 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 16 Feb 2021 | 133,149 | 200,696 | - | 10.0 | 1,332,036 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. | 10 Feb 2021 | 67,534 | 431,590 | - | 1.3 | 87,119 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 67,534 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 10 Feb 2021 | 12,389 | 333,845 | - | 10 | 123,890 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 889,193 | 889,193 | - | - | Employee Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 21 Jan 2021 | 4,462 | 346,234 | - | 10 | 44,620 | Common Stock |
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | 14 Jul 2020 | 437,318 | 0 | - | - | Series A-1 Preferred Stock | ||
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | 14 Jul 2020 | 350,696 | 350,696 | - | - | Common Stock | ||
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | 14 Jul 2020 | 319,039 | 0 | - | - | Series A Preferred Stock | ||
| Poseida Therapeutics Inc | Eric Ostertag | Director, Chief Executive Officer, Ten Percent Owner | 14 Jul 2020 | 255,845 | 629,194 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges